文献速递其他结缔组织病

阿司匹林触发消退素D1可减轻干燥综合征小鼠模型炎症并恢复唾液分泌

Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

该研究在干燥综合征样小鼠模型发病后经尾静脉注射阿司匹林触发消退素D1(AT-RvD1)治疗8周,发现其可恢复雌雄小鼠唾液分泌、减少下颌下腺浸润中的Th17细胞,并降低雌性小鼠促炎因子表达,但未减少总体淋巴细胞浸润,且效应存在性别差异。

要点

  • 发病后给予AT-RvD1可恢复干燥综合征样小鼠雌雄两性的唾液分泌功能。
  • AT-RvD1不减少下颌下腺总体淋巴细胞浸润,但降低浸润中Th17细胞数量。
  • AT-RvD1降低雌性而非雄性小鼠下颌下腺促炎因子基因和蛋白表达。

核心结论

  • 发病后给予AT-RvD1可减少Th17细胞并恢复干燥综合征小鼠模型的唾液腺功能,但效应存在性别差异。

研究设计与样本

  • 在干燥综合征样小鼠模型发病后经尾静脉注射AT-RvD1治疗8周,并设未治疗对照,随后检测唾液腺功能和炎症状态。

主要发现

  • AT-RvD1治疗恢复雌性和雄性干燥综合征样小鼠的唾液分泌。
  • AT-RvD1治疗不减少下颌下腺总体淋巴细胞浸润,但减少雌雄两性浸润中的Th17细胞数量。
  • AT-RvD1降低雌性而非雄性小鼠下颌下腺中干燥综合征相关促炎因子的基因和蛋白表达水平。

临床怎么用

  • 提示AT-RvD1作为发病后干预策略在干燥综合征中具有潜在价值,但需进一步研究性别差异的原因及治疗效应机制。

局限性

  • 研究为小鼠模型,样本量、具体数值和统计结果未在摘要中报告。
  • 治疗效应存在性别差异,雌性小鼠促炎因子下降而雄性未见,机制未明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: SS is characterized by chronic inflammation of the salivary glands leading to loss of secretory function, thereby suggesting specialized pro-resolving mediators targeting inflammation to be a viable option for treating SS. Previous studies demonstrated that aspirin-triggered resolvin D1 (AT-RvD1) prevents chronic inflammation and enhances saliva secretion in a SS-like mouse model when applied before disease onset. However, this therapy cannot be used in SS patients given that diagnosis occurs post-disease onset and no reliable screening methods exist. Therefore, we examined whether treatment with AT-RvD1 reduces SS-like features in a mouse model post-disease onset. METHODS: Tail vein injections were performed in a SS-like mouse model both with and without AT-RvD1 post-disease onset for 8 weeks, with salivary gland function and inflammatory status subsequently determined. RESULTS: Treatment of a SS-like mouse model with AT-RvD1 post-disease onset restores saliva secretion in both females and males. Moreover, although AT-RvD1 treatment does not reduce the overall submandibular gland lymphocytic infiltration, it does reduce the number of T helper 17 cells within the infiltrates in both sexes. Finally, AT-RvD1 reduces SS-associated pro-inflammatory cytokine gene and protein expression levels in submandibular glands from female but not male mice. CONCLUSION: AT-RvD1 treatment administered post-disease onset reduces T helper 17 cells and successfully restores salivary gland function in a SS mouse model with variable effects noted by sex, thus warranting further examination of both the causes for the sex differences and the mechanisms responsible for the observed treatment effect.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Dean S, Wang CS, Nam K, et al. Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model. Rheumatology (Oxford). 2019. PMID: 30877775. doi:10.1093/rheumatology/kez072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。